March 2026 saw the US Food and Drug Administration grant breakthrough device designation to Path Assist Derm, an artificial intelligence (AI) tool that enhances pathology workflows by analysing whole ...

A UAB pathology study reveals Bmal1 as an unexpected driver of diabetic vascular calcification, linking circadian signaling ...

The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...

A new study has found comprehensive evidence that "weight-loss" GLP-1 receptor agonists such as semaglutide are effective in ...

New research suggests gut bacteria differences could signal Parkinson's disease risk years before symptoms emerge, according ...

Techcyte is pleased to announce that a validation study conducted by the Contra Costa County Public Health Laboratory (CCPHL) evaluating its AI-assisted ova and parasite (O&P) workflow has been ...

New research has shown that single blood vessel cells that appear in the earliest stages of lab-grown skin organoids have the ...

Drug Farm today announced ophthalmologic and central nervous system (CNS) findings from its Phase 1b study of DF-003, a first ...

Pregnant women in the United States are routinely tested for gestational diabetes, a condition where the body has high blood ...

BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that it will host ...

A sizeable minority of cases are endocervical, and the Soft-Brush biopsy sampler for the endocervix apparently ...